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BRAINSTEM PHENOTYPE OF CATHEPSIN A–
RELATED ARTERIOPATHY WITH STROKES AND
LEUKOENCEPHALOPATHY
Cathepsin A–related arteriopathy with strokes and
leukoencephalopathy (CARASAL) is a recently
identified cause of adult-onset cerebral leukodystro-
phy due to CTSA gene mutations described in 3
Dutch and British families.1,2 The clinical phenotype
of CARASAL continues to be defined. Here, we
report a British patient with CARASAL with brain-
stem dysfunction as a leading clinical issue.
Case description. A 48-year-old Caucasian woman
(British CARASAL case2) presented with 5 years of
deteriorating concentration and behavioral disinhi-
bition. Recently, she had developed alternating
right- or left-sided facial pain of fluctuating inten-
sity, which was ameliorated with carbamazepine.
She also reported prominent, nonpositional vertigo,
difficulty following conversations in noisy environ-
ments, hyperacusis, tinnitus, and hoarseness. Her
sleep was disturbed by vivid nightmares and fre-
quent intrusive leg movements. Medical history
included migraine, hypertension, sinusitis, asthma,
and depression. In the family history, her father died
at age 60 years after a stroke, and several paternal
relatives reportedly had young onset cognitive
decline, although no details were available. Her
Folstein Mini-Mental State Examination score was
27/30, losing points for orientation and generation
of a novel sentence, and there was bedside evidence
of executive dysfunction and cognitive slowing,
despite preserved memory and perceptual functions,
corroborated on neuropsychometry. The general
neurologic examination was unremarkable.
Brain MRI (figure, A–D) revealed diffuse, conflu-
ent T2-weighted hyperintensity of supratentorial white
matter, basal ganglia, and thalamus with extensive
involvement of midbrain, pons, and medulla, includ-
ing auditory pathways. Pure tone audiometry revealed
sensorineural hearing loss with a “cookie-bite” profile
most marked for midfrequencies and transient otoa-
coustic emissions, consistent with mild genetic
cochlear dysfunction (figure, E; table e-1 at Neurol-
ogy.org/ng). Auditory evoked brainstem responses at
6 kHz showed delayed wave V (figure, F; table e-2):
this was not attributable to cochlear dysfunction
(given the normal wave I latency and 6–8 kHz tone
detection; figure, E, tables e-1 and e-2). Furthermore,
a test of spatial noise perception3 showed abnormal
binaural interaction (table e-3), indicating (together
with the brainstem evoked responses) superior olivary
nuclei involvement. Peripheral vestibular assessment
with electronystagmography and caloric tests revealed
subtle smooth pursuit deficits, consistent with a brain-
stem localization. Polysomnography revealed moderate
periodic limb movements of sleep and (although
there was no dream enactment) loss of REM atonia,
suggestive of REM sleep behavior disorder.
Extensive investigations for metabolic and genetic
causes of leukodystrophy proved unrevealing until the
patient was ultimately shown to have a pathogenic
c.973C.T, p.R325C missense mutation in the
CTSA gene, confirming the diagnosis of CARASAL.1
The patient was found to share allele 123 at marker
D20S838, indicating a common genetic ancestry
with previously reported Dutch cases.1
Discussion. Initial descriptions of CARASAL have
emphasized stroke as a dominant clinical feature
and relatively indolent cognitive decline, although
most patients have had memory complaints at presen-
tation.1 In the series reported by Bugiani et al.,1
symptoms of lower cranial nerve dysfunction (includ-
ing vertigo, dysphagia, dry mouth, dry eyes, central
facial paresis, or dysarthria) occurred in approximately
70% of cases, and refractory hypertension was a fur-
ther clinical hallmark. MRI changes commonly
involve brainstem white matter with additional
involvement of the thalami and other gray matter
nuclei,1 as in our case (figure, A–D). The audioves-
tibular test profile here indicated a brainstem lesion,
in addition to mild cochlear dysfunction of uncertain
provenance. Considered collectively, the available evi-
dence suggests a potential brainstem substrate for the
symptom complex of facial pain, vertigo, hearing al-
terations, hoarseness, and sleep disorder exhibited by
our patient and similar symptoms described in pre-
vious cases of CARASAL. The potential value of
brainstem involvement in the differential diagnosis
of CARASAL and related entities has not been pre-
viously emphasized.
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At present, clinical differentiation of the cerebral
arteriopathies exemplified by CARASAL, CARASIL,
and CADASIL remains challenging.4 Although radio-
logic involvement of brainstem white matter tracts is
frequently observed, neuro-otologic and other symp-
toms referable to brainstem structures are relatively
uncommon in adult-onset leukodystrophies.5 In
CADASIL, such symptoms are generally less salient
than cognitive and psychiatric decline.6 Based on the
clinical evidence of the present case, we propose that
CARASAL should be considered in patients with
adult-onset leukoencephalopathy and prominent
early symptoms implicating a brainstem origin. This
proposal carries the caveat that clinical experience
with CARASAL remains limited (at present, a single
genetic variant1). Although the true prevalence and
mechanism remain speculative, pending further stud-
ies in larger cohorts with neuropathologic correlation,
brainstem features in CARASAL could reflect dual
effects of dystrophic white matter tracts and impaired
perfusion of cranial nerve nuclei due to perforant
arteriopathy: a mechanism previously proposed to
underpin selective brainstem damage in CADASIL.7
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Figure MRI and neuro-otologic findings in the present case
Axial T2-weighted MRI sections through the brainstem (A–C) and a coronal fluid-attenuated inversion recovery MRI section through the thalami (D) are
shown. Red arrows (A) indicate involvement of the lateral lemnisci; dotted white arrows (B) indicate involvement of the superior olivary nuclei; solid white
arrows (C) indicate involvement of the dorsal, ventral, and inferior olivary nuclei. Pure tone audiometry plots (E) illustrate a “cookie-bite” profile of mild
midfrequency hearing loss in both right (red) and left (blue) ears (threshold [dB] on y axis, abnormal.20 dB; table e-1). Auditory brainstem evoked responses
(F); 3 recordings displayed for left (above) and right (below) ears showing that peaks (length of vertical latency marker indicates amplitude 0.2 mV) for wave V
are consistently delayed beyond the normal range (gray oblongs) and normal latencies for waves I and III, indicating dysfunction of brainstem pathways
between ventral cochlear nuclei and nucleus of the lateral lemniscus (table e-2). Note that these brainstem responses were evoked by a 6-kHz tone, which
had a normal pure tone audiometric threshold for both ears (E).
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